Free Trial

Merck KGaA (ETR:MRK) Trading Up 2.7% - Here's What Happened

Merck KGaA logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Merck KGaA shares were up 2.7% on Thursday, trading as high as €106.40 and last at €106.15 on volume of 317,358 shares, versus a prior close of €103.35.
  • The stock is trading below its 50‑day (€120.70) and 200‑day (€117.60) moving averages; the company has a market capitalization of $47.27 billion, a P/E of 17.44 and a PEG of 2.37.
  • Merck KGaA is a German science and technology company operating through Life Science, Healthcare, and Electronics segments, with the Life Science unit providing lab tools, reagents, testing services and bioprocessing technologies to biotech and pharma customers.
  • MarketBeat previews the top five stocks to own by May 1st.

Merck KGaA (ETR:MRK - Get Free Report) shares traded up 2.7% during trading on Thursday . The company traded as high as €106.40 and last traded at €106.15. 317,358 shares traded hands during mid-day trading, The stock had previously closed at €103.35.

Merck KGaA Stock Performance

The firm has a fifty day moving average of €120.70 and a 200 day moving average of €117.60. The company has a debt-to-equity ratio of 41.86, a current ratio of 1.46 and a quick ratio of 0.72. The stock has a market capitalization of $47.27 billion, a price-to-earnings ratio of 17.44, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines